Loading…
Lobbying Spend
—
Filings
57
Firms Hired
1
Active Period
2007–2026
Client-reported lobbying expenses on LDA filings
Lobbying firms retained by this client; amounts are client-reported expenses when available
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
Medicare contractor issues related to coverage and reimbursement for drugs, including accreditation issues. Clinical Laboratory Fee Schedule and Physician Fee Schedule Proposed Medicare Rules. S. 2761/H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (The RESULTS Act).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5269
Medicare contractor issues related to coverage and reimbursement for drugs, including accreditation issues. Clinical Laboratory Fee Schedule and Physician Fee Schedule Proposed Medicare Rules. S. 2761/H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (The RESULTS Act).
Client expense: — · Firm income: $30,000
Matched citations: S. 2761
Medicare contractor issues related to coverage and reimbursement for drugs. Clinical Laboratory Fee Schedule and Physician Fee Schedule Proposed Medicare Rules. S. 2761/H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (The RESULTS Act).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5269
Medicare contractor issues related to coverage and reimbursement for drugs. Clinical Laboratory Fee Schedule and Physician Fee Schedule Proposed Medicare Rules. S. 2761/H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (The RESULTS Act).
Client expense: — · Firm income: $30,000
Matched citations: S. 2761
Medicare contractor issues related to coverage and reimbursement for drugs. Clinical Laboratory Fee Schedule and Physician Fee Schedule Proposed Medicare Rules. S. 2761/H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (The RESULTS Act).
Client expense: — · Firm income: $30,000
Matched citations: H.R. 5269
Medicare contractor issues related to coverage and reimbursement for drugs. Clinical Laboratory Fee Schedule and Physician Fee Schedule Proposed Medicare Rules. S. 2761/H.R. 5269, the Reforming and Enhancing Sustainable Updates to Laboratory Testing Services Act of 2025 (The RESULTS Act).
Client expense: — · Firm income: $30,000
Matched citations: S. 2761
American Relief Act, 2025
2024 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues related to coverage and reimbursement for drugs of abuse testing. Access to COVID-19 laboratory testing. H.R. 9747 (Pub. L. 118-83) - Continuing Appropriations and Extensions Act, 2025. Protecting Access to Medicare Act (PAMA) - Delaying laboratory payment reductions. H.R. 10545 - The American Relief Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 10545
Continuing Appropriations and Extensions Act, 2025
2024 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues related to coverage and reimbursement for drugs of abuse testing. Access to COVID-19 laboratory testing. H.R. 9747 (Pub. L. 118-83) - Continuing Appropriations and Extensions Act, 2025. Protecting Access to Medicare Act (PAMA) - Delaying laboratory payment reductions. H.R. 10545 - The American Relief Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 9747
Continuing Appropriations and Extensions Act, 2025
2024 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues related to coverage and reimbursement for drugs of abuse testing. Access to COVID-19 laboratory testing. H.R. 9747 (Pub. L. 118-83) - Continuing Appropriations and Extensions Act, 2025. Protecting Access to Medicare Act (PAMA) - Delaying laboratory payment reductions.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 9747
Further Continuing Appropriations and Other Extensions Act, 2024
2023 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues related to coverage and reimbursement for drugs of abuse testing. Access to COVID-19 laboratory testing. H.R. 6363 - Further Continuing Appropriations and Other Extensions Act, 2024
Client expense: — · Firm income: $30,000
Matched citations: H.R. 6363
Consolidated Appropriations Act, 2023
2022 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues regarding coverage of testing for opioids, drugs of abuse, and drug interactions. Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses. Protecting Access to Medicare Act Laboratory reimbursement reporting delay; Medicare reimbursement for laboratory services. H.R. 2617 - Consolidated Appropriations Act, 2023. H.R. 8111/S. 4449 - Saving Access to Laboratory Services Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2617
My Body, My Data Act of 2022
2022 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues regarding coverage of testing for opioids, drugs of abuse, and drug interactions. Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses. Protecting Access to Medicare Act Laboratory reimbursement reporting delay; Medicare reimbursement for laboratory services. H.R. 2617 - Consolidated Appropriations Act, 2023. H.R. 8111/S. 4449 - Saving Access to Laboratory Services Act.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 8111
Saving Access to Laboratory Services Act
2022 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues regarding coverage of testing for opioids, drugs of abuse, and drug interactions. Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses. Protecting Access to Medicare Act Laboratory reimbursement reporting delay; Medicare reimbursement for laboratory services. H.R. 2617 - Consolidated Appropriations Act, 2023. H.R. 8111/S. 4449 - Saving Access to Laboratory Services Act.
Client expense: — · Firm income: $30,000
Matched citations: S. 4449
Consolidated Appropriations Act, 2022
2022 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses Issues related to government funding and support for COVID testing. Access to COVID-19 testing. H.R. 2471 - Consolidated Appropriations Act (2022 Omnibus). H.R. 7007 - COVID-19 Supplemental Appropriations Act of 2022.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2471
Consolidated Appropriations Act, 2022
2022 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues regarding coverage of testing for opioids, drugs of abuse, and drug interactions. Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses. Protecting Access to Medicare Act Laboratory reimbursement reporting delay; Medicare reimbursement for laboratory services. H.R. 2471 - Consolidated Appropriations Act (2022 Omnibus). H.R. 7007 - COVID-19 Supplemental Appropriations Act of 2022.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 2471
COVID Supplemental Appropriations Act, 2022
2022 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses Issues related to government funding and support for COVID testing. Access to COVID-19 testing. H.R. 2471 - Consolidated Appropriations Act (2022 Omnibus). H.R. 7007 - COVID-19 Supplemental Appropriations Act of 2022.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7007
COVID Supplemental Appropriations Act, 2022
2022 · first_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues regarding coverage of testing for opioids, drugs of abuse, and drug interactions. Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses. Protecting Access to Medicare Act Laboratory reimbursement reporting delay; Medicare reimbursement for laboratory services. H.R. 2471 - Consolidated Appropriations Act (2022 Omnibus). H.R. 7007 - COVID-19 Supplemental Appropriations Act of 2022.
Client expense: — · Firm income: $30,000
Matched citations: H.R. 7007
Consolidated Appropriations Act, 2021
2020 · fourth_quarter · Firm: MEHLMAN CONSULTING, INC.
Referral issues regarding laboratory testing. Reimbursement for COVID-19-related expenses H.R. 133 - Consolidated Appropriations Act, 2021. Issues related to government funding and support for COVID testing.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 133
Paycheck Protection Program and Health Care Enhancement Act
2020 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Referral issues regarding laboratory testing. H.R. 3584 - Laboratory Access for Beneficiaries Act. Reimbursement for COVID-19-related expenses H.R. 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 266 - Paycheck Protection Program and Health Care Enhancement Act S. 178, HEALS Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 266
Paycheck Protection Program and Health Care Enhancement Act
2020 · third_quarter · Firm: MEHLMAN CONSULTING, INC.
Medicare contractor issues regarding coverage of testing for opioids, drugs of abuse, and drug interactions. Referral issues regarding laboratory testing. H.R. 3584 - Laboratory Access for Beneficiaries Act. Reimbursement for COVID-19-related expenses H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 266, Paycheck Protection Program and Health Care Enhancement Act S. 178, HEALS Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 266
Referral issues regarding laboratory testing. H.R. 3584 - Laboratory Access for Beneficiaries Act. Reimbursement for COVID-19-related expenses H.R. 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 266 - Paycheck Protection Program and Health Care Enhancement Act S. 178, HEALS Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3584
Medicare contractor issues regarding coverage of testing for opioids, drugs of abuse, and drug interactions. Referral issues regarding laboratory testing. H.R. 3584 - Laboratory Access for Beneficiaries Act. Reimbursement for COVID-19-related expenses H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 266, Paycheck Protection Program and Health Care Enhancement Act S. 178, HEALS Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 3584
Referral issues regarding laboratory testing. H.R. 3584 - Laboratory Access for Beneficiaries Act. Reimbursement for COVID-19-related expenses H.R. 748 - Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 266 - Paycheck Protection Program and Health Care Enhancement Act S. 178, HEALS Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 748
Medicare contractor issues regarding coverage of testing for opioids, drugs of abuse, and drug interactions. Referral issues regarding laboratory testing. H.R. 3584 - Laboratory Access for Beneficiaries Act. Reimbursement for COVID-19-related expenses H.R. 748, Coronavirus Aid, Relief, and Economic Security (CARES) Act H.R. 266, Paycheck Protection Program and Health Care Enhancement Act S. 178, HEALS Act
Client expense: — · Firm income: $20,000
Matched citations: H.R. 748
H.R. 748, the Coronavirus Aid, Relief, and Economic Security (CARES) Act - Public Law No: 116-136; Provisions related to coverage of diagnostic testing
Client expense: — · Firm income: $20,000
Matched citations: H.R. 748
Source: Senate LDA